FDA approves new treatment for adults with migraine - FDA Press Releases

FDA approves Ubrelvy (ubrogepant) tablets for the acute treatment of migraine with or without aura in adults.

from FDA Press Releases RSS Feed https://ift.tt/2sW0Vd7
via IFTTT